Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019
CAMBRIDGE, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing […]